Alidjanov, Jakhongir F. http://orcid.org/0000-0003-2531-4877
Khudaybergenov, Ulugbek A. http://orcid.org/0000-0002-0018-8045
Ayubov, Bekhzod A. http://orcid.org/0000-0001-6857-6864
Pilatz, Adrian http://orcid.org/0000-0001-8072-1841
Mohr, Stefan http://orcid.org/0000-0002-7218-4908
Münst, Julia C. http://orcid.org/0000-0003-1820-7838
Ziviello Yuen, Olivia N.
Pilatz, Sabine
Christmann, Corina
Dittmar, Florian
Mirsaidov, Nodir M.
Buch-Heberling, Mareike
Naber, Kurt G. http://orcid.org/0000-0003-1304-5403
Bjerklund Johansen, Truls E. http://orcid.org/0000-0003-3490-6460
Wagenlehner, Florian M. E. http://orcid.org/0000-0002-2909-0797
Funding for this research was provided by:
Justus-Liebig-Universität Gießen
Article History
Received: 7 February 2021
Accepted: 19 May 2021
First Online: 25 June 2021
Declarations
:
: The primary study protocol was approved by the Ethical Committee of the Justus Liebig University of Giessen (AZ: 10/15, from August 4, 2015). Ethical approval and regulatory issues of participating clinics were the individual clinic’s responsibility.All procedures performed in studies involving human participants followed the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual respondents recruited in the study.
: Written informed consent for publication of the results of the analysis of anonymized data was obtained from all individual respondents recruited in the study.
: JFA, KGN, FMW and AP are authors and copyright holders of the ACSS questionnaire.JFA, KGN, FMW and TEBJ are scientific advisors of OM-Pharma.JFA declares a personal conflict of interest with Elsevier publishing company due to personal disagreement with the policy of the company.Remaining authors claim no conflict of interest.